Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.
Article
in English
| IMSEAR
| ID: sea-45576
ABSTRACT
BACKGROUND:
Recombinant activated factor VII is used for the treatment in patients with inherited or acquired hemophilia with inhibitors and congenital factor VII deficiencies.OBJECTIVE:
Using recombinant activated factor VII in primary postpartum hemorrhage. MATERIAL ANDMETHOD:
Two cases of women who had postpartum hemorrhage and were treated with recombinant activated factor VII after all conventional treatment failed.RESULTS:
The intractable hemorrhage stopped after treatment with recombinant activated factor VIICONCLUSION:
The present report showed that massive postpartum hemorrhage that failed to all procedures was controlled successfully by recombinant activated factor VII.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Recombinant Proteins
/
Female
/
Humans
/
Pregnancy
/
Factor VIIa
/
Treatment Outcome
/
Treatment Failure
/
Adult
/
Postpartum Hemorrhage
Language:
English
Year:
2007
Type:
Article
Similar
MEDLINE
...
LILACS
LIS